BioRestorative Therapies to Showcase Advances in Regenerative Medicine
BioRestorative Therapies, Inc. (NASDAQ: BRTX), a leader in regenerative medicine focused on stem cell therapies, has announced its participation in important upcoming investor events. The company is dedicated to pioneering advancements in regenerative medicine and has made significant strides in developing innovative therapies.
Upcoming Investor Engagements
The company is set to take part in two significant investor events this month:
UBS Virtual Organ Restoration and Cell Therapy Day
Lance Alstodt, the CEO of BioRestorative, will engage in a fireside chat with UBS's analyst, Ash Verma, who specializes in biotech and specialty pharma. This session will take place at 1:00 p.m. ET on October 15, 2024. This event will provide investors with insights into BioRestorative's operations and future prospects in cell therapy.
Maxim Healthcare Virtual Summit
Another engagement on the calendar is the 2024 Maxim Healthcare Virtual Summit. Mr. Alstodt will again be featured in a discussion with Jason McCarthy, Ph.D., who heads biotechnology research at Maxim Group. This chat, scheduled for October 17, 2024, at 11:00 a.m. ET, promises to delve deeper into the company’s innovative approaches and therapeutic developments.
About BioRestorative Therapies, Inc.
BioRestorative Therapies aims to develop cutting-edge therapeutic products based on advanced cell and tissue protocols, predominantly leveraging adult stem cells. The company has two primary clinical programs that address significant health concerns, particularly in the realm of regenerative therapies.
Disc/Spine Program: brtxDISC™
The flagship therapy, BRTX-100, utilizes a patient’s own cultured mesenchymal stem cells harvested from their bone marrow. This treatment is designed for non-surgical interventions to relieve pain caused by lumbosacral disc disorders. By employing proprietary technology, BioRestorative collects, cultures, and cryopreserves the stem cells, which are then injected into the affected discs by a health professional. The company is currently in its Phase 2 clinical trial, demonstrating its commitment to innovative solutions for chronic lower back pain management.
Metabolic Program: ThermoStem®
In addition to spinal therapies, BioRestorative is developing therapies to manage obesity and metabolic disorders. This program harnesses brown adipose derived stem cells (BADSC) to create brown adipose tissue (BAT), which plays a crucial role in energy metabolism. Preclinical studies suggest that individuals with higher brown fat levels may experience less obesity and improved metabolic functions, making this line of research particularly promising for future therapeutic options.
BioCosmeceuticals: A New Frontier
Complementing its clinical programs, BioRestorative also operates in the aesthetic domain with its BioCosmeceutical platform. The company has developed a proprietary serum that combines exosomes, proteins, and growth factors aimed at enhancing skin appearance and mitigating aging signs. This product is manufactured in a clean room environment compliant with cGMP standards, emphasizing safety and efficacy in its formulations. Future endeavors include expanding the product line to cover a wider range of cell-based aesthetic therapies, potentially leading to FDA approvals as the company strives to innovate within the burgeoning BioCosmeceutical market.
Frequently Asked Questions
What is BioRestorative Therapies' primary focus?
BioRestorative Therapies focuses on developing regenerative medicine therapies, particularly those involving stem cell-based treatments.
What events will the company participate in?
BioRestorative Therapies will take part in the UBS Virtual Organ Restoration and Cell Therapy Day and the Maxim Healthcare Virtual Summit.
What is BRTX-100?
BRTX-100 is BioRestorative’s lead cell therapy candidate aimed at treating disc disorders non-surgically by utilizing the patient’s own stem cells.
How does the ThermoStem® program work?
ThermoStem® utilizes brown adipose derived stem cells to target obesity and metabolic issues by increasing brown adipose tissue, aiding in energy metabolism.
What are BioCosmeceuticals?
BioCosmeceuticals are products developed by BioRestorative that use cellular technology to enhance cosmetic outcomes, including reducing the visibility of fine lines.
